close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protokinetix Inc (OP:PKTX)

0.0052 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EST, Feb 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0052
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0052
Today's Range 0.0052 - 0.0052
52wk Range 0.0040 - 0.0149
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying ↗
The Dow Jones index closed lower by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Insiders Buying ProtoKinetix And 2 Other Stocks Under $2 ↗
The Dow Jones closed lower by over 350 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Topics Stocks

Performance

YTD
-20.0%
-20.0%
1 Month
-13.3%
-13.3%
3 Month
-24.6%
-24.6%
6 Month
-30.7%
-30.7%
1 Year
-51.4%
-51.4%

More News

Read More
News headline image
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
AIM ImmunoTech, InnSuites Hospitality Trust And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
Via Benzinga
News headline image
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
Around $12 Million Bet On Sonim Technologies? 4 Penny Stocks Insiders Are Buying ↗
Via Benzinga
News headline image
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
4 Penny Stocks Insiders Are Buying ↗
Via Benzinga
News headline image
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
4 Penny Stocks Insiders Are Buying ↗
Via Benzinga
News headline image
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration
From ProtoKinetix, Incorporated
Via Business Wire

Frequently Asked Questions

Is Protokinetix Inc publicly traded?
Yes, Protokinetix Inc is publicly traded.
What exchange does Protokinetix Inc trade on?
Protokinetix Inc trades on the OTC Traded
What is the ticker symbol for Protokinetix Inc?
The ticker symbol for Protokinetix Inc is PKTX on the OTC Traded
What is the current price of Protokinetix Inc?
The current price of Protokinetix Inc is 0.0052
When was Protokinetix Inc last traded?
The last trade of Protokinetix Inc was at 02/05/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today